<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48580">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01894828</url>
  </required_header>
  <id_info>
    <org_study_id>Nutri01</org_study_id>
    <nct_id>NCT01894828</nct_id>
  </id_info>
  <brief_title>Nutritional Supplementation in Patients With no Signs of Malnutrition</brief_title>
  <official_title>The Effect of Nutritional Supplementation in Cancer Patients With no Clinical Signs of Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedSource Polska</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedSource Polska</source>
  <oversight_info>
    <authority>Poland: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to assess the effect of nutritional supplementation on nutritional
      status and postoperational complications in cancer patients with no clinical signs of
      malnutrition
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In previous psychological studies our team found high level psychological stress in over 60%
      of cancer patients. This may cause numerous problems including anorexia, which together with
      biological disturbances can initiate cancer related catabolism even when it can not yet be
      seen. In this study we want to answer the question if oral nutritional supplementation can
      help the patient overcome the catabolism in its initial phase and improve nutritional
      status, which would result in reduced number of postoperational complications
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2011</start_date>
  <primary_completion_date type="Anticipated">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>Improvement of nutritional status</measure>
    <time_frame>After 14 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>The aim of the study was to assess if nutritional supplementation improves nutritional status of patients with no clinical signs of malnutrition. Nutritional status improvement will be assessed by change in anthropometric (body weight (kg)) and laboratory (albumin, total protein, transferrin level, total lymphocyte count) parameters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reducing number of complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess if improvement of nutritional status is connected with reduced number of postoperative complications.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Primary Neoplasm</condition>
  <condition>Secondary Neoplasm</condition>
  <condition>Abdominal Neoplasm</condition>
  <arm_group>
    <arm_group_label>Nutritional supplements</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are asked to drink two 200ml bottles of nutritional supplement daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients are asked to keep on to their normal diet. No supplementation is introduced</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nutritional supplements</intervention_name>
    <description>Patients are asked to drink two 200ml bottles of nutritional supplement daily for 14 days before surgery</description>
    <arm_group_label>Nutritional supplements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary or secondary resectable gastrointestinal and abdominal malignancy

          -  No signs of malnutrition at qualification for surgery

          -  General performance &gt;70 Karnofsky scale

          -  Informed consent

        Exclusion Criteria:

          -  history of radio or chemotherapy

          -  signs of mechanical ileus

          -  other major gastrointestinal diseases

          -  type 1 diabetes

          -  autoimmunological diseases requiring systemic steroids

          -  signs of infection

          -  renal and/or liver failure
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paweł Kabata, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Surgical Oncology Medical University of Gdańsk</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tomasz Jastrzębski, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Surgical Oncology Medical University of Gdańsk</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paweł Kabata, MD</last_name>
    <phone>+48509707959</phone>
    <email>pawel.kabata@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tomasz Jastrzębski, Prof</last_name>
    <phone>+48583493190</phone>
    <email>jasek@post.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgical Oncology Medical University of Gdańsk</name>
      <address>
        <city>Gdańsk</city>
        <state>Pomorskie</state>
        <zip>80-210</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paweł Kabata, MD</last_name>
      <phone>+48509707959</phone>
      <email>pawel.kabata@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Paweł Kabata, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomasz Jastrzębski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michał Kąkol, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karolina Król, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 9, 2013</lastchanged_date>
  <firstreceived_date>July 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nutritional support</keyword>
  <keyword>Gastrointestinal cancer</keyword>
  <keyword>Malnutrition</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abdominal Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
